American Pain Society

Virpax Pharmaceuticals to Utilize Dr. Neil K. Singla to Assist in Development of Probudur™

Retrieved on: 
Wednesday, January 18, 2023

Probudur’s proprietary formulation is intended for immediate onset and has demonstrated sustained pain control for up to 96 hours in animal studies.

Key Points: 
  • Probudur’s proprietary formulation is intended for immediate onset and has demonstrated sustained pain control for up to 96 hours in animal studies.
  • Dr. Neil Singla is board certified in Anesthesiology and the Founder and Chief Scientific Officer of Lotus Clinical Research, a leading analgesic clinical research organization (CRO) with extensive analgesic and pain-related expertise.
  • Dr. Singla has published extensively and is a frequent lecturer for physicians, pharmaceutical companies, and medical research institutes throughout the country.
  • “Virpax is actively moving its programs forward in anticipation of filing Investigational New Drug applications (INDs) and beginning human clinical trials.

Edgar Ross, M.D., Renowned Pain Expert and Director of Pain Management at Harvard University, Joins Harvard MedTech’s Medical Advisory Board

Retrieved on: 
Tuesday, September 27, 2022

Edgar Ross, M.D., one of the nation's most renowned pain experts, is joining the Medical Advisory Board of Harvard MedTech .

Key Points: 
  • Edgar Ross, M.D., one of the nation's most renowned pain experts, is joining the Medical Advisory Board of Harvard MedTech .
  • We are honored to have one of the nations foremost authorities on pain management join Harvard MedTechs Medical Advisory Board, said Gerry Stanley, M.D., Chief Medical Officer, Harvard MedTech.
  • Like Harvard MedTech, he is committed to reversing the opioid crisis and ensuring non-addictive treatments become more mainstream in the management of injured workers.
  • Dr. Ross is considered one of the leading pain management physicians in the world and is recognized for his contributions to the field of pain management across the globe.

Ascellus Announces Publication of a Study Addressing the Mental Health Factors for Improving Outcomes in Work-Related COVID-19

Retrieved on: 
Tuesday, August 9, 2022

These findings contribute to the continually expanding research demonstrating the positive effects that CBT has on improving the health of injured workers whose physical injuries are complicated by psychological distress.

Key Points: 
  • These findings contribute to the continually expanding research demonstrating the positive effects that CBT has on improving the health of injured workers whose physical injuries are complicated by psychological distress.
  • Published in The Journal of Occupational and Environmental Medicine, the study is titled Addressing Mental Health Factors to Improve Outcomes in Work-Related COVID-19.
  • Ascellus provides evidence-based treatment for pain management, workplace trauma, posttraumatic stress disorder (PTSD), head injury/mTBI, COVID-19 and California Stress Claims.
  • Ascellus is the leading behavioral health platform focused on helping injured workers restore their physical and mental wellbeing.